Absci

GRCHealthcare

Creating Drugs at the Speed of Ai. Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

2010
Founded
16y
Age
$319M
Total funding
Healthcare
Area

Funding timeline

Oct 2024
Post-IPO Secondary - Absci
Feb 2024
Post-IPO Equity - Absci
Members only
Mar 2021
Venture Round - Absci
Members only
Feb 2021
Corporate Round - Absci
Oct 2020
Series E - Absci
Members only
Jan 2020
Series D - Absci
Members only
Dec 2019
Debt Financing - Absci
Members only
Jan 2019
Series D - Absci
Members only
May 2018
Series C - Absci
Members only
Aug 2017
Series B - Absci
Feb 2016
Series A - Absci
Members only

8 earlier round amounts are shown to members.

Create a free account